Title :
Multi-isotype Glycoproteomic Characterization of Serum Antibody
Heavy Chains Reveals Isotype- and Subclass-Specific N-Glycosylation Profiles
Abstract :
- Antibodies are critical glycoproteins that bridge the innate and adaptive immune systems to provide protection against infection
- The isotype/subclass of the antibody, the co-translational N-glycosylation on the CH2 domain, and the remodeling of the N-linked glycans during passage through the ER and Golgi are the known variables within the Fc domain that program antibody effector function
- Through investigations of monoclonal therapeutics, it has been observed that addition or removal of specific monosaccharide residues from antibody N-glycans can influence the potency of antibodies, highlighting the importance of thoroughly characterizing antibody N-glycosylation
- Although IgGs usually have a single N-glycosylation site and are well studied, other antibody isotypes, e.g. IgA and IgM , that are the first responders in certain diseases, have two to five sites/monomer of antibody, and little is known about their N-glycosylation
- Here we employ a nLC-MS/MS method using stepped-energy higher energy collisional dissociation to characterize the N-glycan repertoire and site occupancy of circulating serum antibodies
- We simultaneously determined the site-specific N-linked glycan repertoire for IgG1 , IgG4 , IgA1 , IgA2 , and IgM in individual healthy donors
- Compared with IgG1 , IgG4 displayed a higher relative abundance of G1S1F and a lower relative abundance of G1FB
- IgA1 and IgA2 displayed mostly biantennary N-glycans
- IgA2 variants with the either serine (S93) or proline (P93) were detected
- In digests of the sera from a subset of donors, we detected an unmodified peptide containing a proline residue at position 93 ; this substitution would strongly disfavor N-glycosylation at N92
- IgM sites N46, N209, and N272 displayed mostly complex glycans, whereas sites N279 and N439 displayed higher relative abundances of high-mannose glycoforms
- This multi-isotype approach is a crucial step toward developing a platform to define disease-specific N-glycan signatures for different isotypes to help tune antibodies to induce protection
- Data are available via ProteomeXchange with identifier PXD010911
Output (sent_index, trigger,
protein,
sugar,
site):
Output(Part-Of) (sent_index,
protein,
site):
*Output_Site_Fusion* (sent_index,
protein,
sugar,
site):